Future Medicinal Chemistry

Papers
(The H4-Index of Future Medicinal Chemistry is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
CK1 Delta Inhibition: An Emerging Strategy to Combat Neurodegenerative Diseases62
Proteolysis-Targeting Chimera Molecules Targeting SHP255
Novel coumarin linked pyrazoles, thiazoles, and thiadiazoles: synthetic strategies and in vitro antimicrobial investigation45
Design, Synthesis and Exploration of Novel Triazinoindoles as Potent Quorum-Sensing Inhibitors and Radical Quenchers37
Chemical and Biological Versatility of Pyrazolo[3,4- d ]Pyrimidines: One Scaffold, Multiple Modes of Action36
Enhancing the Affinity of Novel GLS1 Allosteric Inhibitors By Targeting Key Residue Lys32034
Chemical Language Models for Applications in Medicinal Chemistry33
Panantiviral Agents: Implications for Treating Cancers Associated With Oncoviruses33
Using Novel Click Chemistry Algorithm to Design D3R Inhibitors As Blood–Brain Barrier Permeants32
New Thiouracil Derivatives As Histone Deacetylase Inhibitors and Apoptosis Inducers: Design, Synthesis and Anticancer Evaluation30
Novel Hydroxy- and Amidino-Substituted Benzimidazoles and Benzothiazoles as Antibacterial and Antiproliferative Agents29
Exploitation of a Novel Allosteric Binding Region in DNA Gyrase and its Implications for Antibacterial Drug Discovery29
Targeting LRRK2 Mutations in Parkinson's Disease25
In Silico Multiscale Drug Design to Discover Key Structural Features of Potential JAK2 Inhibitors25
Welcome to the 16th Volume of Future Medicinal Chemistry24
Leishmanicidal Activity and 4D Quantitative Structure–Activity Relationship and Molecular Docking Studies of Vanillin-Containing 1,2,3-Triazole Derivatives24
Advances in Non-Covalent Based Inhibitors Targeting Myc: A Promising Approach for Cancer Treatment22
PPARγ Transcription Effect on Naturally Occurring O -Prenyl Cinnamaldehydes and Cinnamyl Alcohol Derivatives22
P2Y14R for Inflammation Therapy: Is It a Promising target?21
Discovery of α-Helix-Mimicking Sulfono-γ-AApeptides as p53−MDM2 Inhibitors20
0.29635119438171